INTRODUCTION
parameters as the reference criterion for a comparison in diagnosis (8) (9) (10) (11) (12) (13) . The rate of false positives (5-37%) (2, (14) (15) (16) (17) (18) and false negatives (2-18%) (19) (20) (21) (22) (23) of tissue and fluid culture decreases their accuracy in the diagnosis of PJI. A new standard that is accurate and efficient is needed in order to minimize a delay in diagnosis, prevent misdiagnosis, and provide the best treatment option in each case. Ambiguous diagnosis in PJI cases creates significant psychological stress for both patients and surgeons looking for the best treatment options for these revision arthroplasty cases. Moreover, the financial burden of a revision arthroplasty is increased when the revision operation is for PJI, as these cases are estimated to cost $60,000 more than mechanical revisions (24) . Revisions associated with infection can lead to a higher number of hospitalizations, more days in the hospital, more operations, more outpatient visits, and also increased outpatient charges compared to revisions associated with mechanical failure (24) . Proper surgical planning for revision arthroplasty relies not only on an accurate diagnosis of infected joints, but also on isolation of the causative organism, as treatment population, 28% underwent irrigation and debridement with retention of components, 48% required two-stage resection arthroplasty for underlying infection, and 13% received a one-stage reimplantation (25) . The remaining 11% were patients who were later diagnosed as infected after an original revision for mechanical failure. In order to assess the accuracy of ESR and CRP tests in the diagnosis of PJI, receiver operating-characteristic curves (ROC) were calculated for each test. ROC allows for a visualization of the relationship between true-positives (sensitivity) and false-positives (1-specificity). Area under the curve (AUC) is determined and is considered a measurement of accuracy for each test. An AUC equal to 1 denotes 100% sensitivity and specificity, or an ideal test. An AUC > 0.9 is considered an excellent test, while an AUC < 0.5 is less helpful (25) . In order to determine the diagnostic cut off levels of ESR and CRP, values corresponding to the points on the ROC curves nearest the upper left hand corner of the graph were chosen to establish an optimal balance between sensitivity and specificity in diagnosing PJI. These values were determined to be 31 mm/h (ESR) and 20.5 mg/l (CRP) (25) (Fig. 1) . The next phase involved evaluation and comparison of sensitivity, specificity, positive and negative predictive values for cut-offs frequently used in literature (30 mm/h ESR and 10 mg/l CRP) with ROC-determined cut-off values (31 mm/h ESR and 20.5 mg/l CRP). when using the ROC-determined cut-off value of the two tests in combination (either/or scenario), we were able to improve sensitivity and negative likelihood ratio compared to both tests being used separately (Tab. I). The overall success rate increases when the two tests are used in combination as the rate of false negatives from misdiagnosed cases drops to 2.7%. varies accordingly. The issue of antibiotic resistance is of considerable concern due to the increase in PJI cases caused by resistant organisms. There is a higher cost associated with the treatment of infections with methicillin-resistant organisms. The cost of antibiotic resistance averages $107,264 per case versus $68,053 in each PJI case caused by non-resistant strains (24) . Surgeons at the Rothman Institute have long been focused on the challenges of PJI, and have implemented an extensive strategy in order to combat these issues on several fronts. Discovery and utilization of molecular markers that can serve as a diagnostic tool in PJI has become the aim of research. The development of firm diagnostic criteria in order to properly identify and treat periprosthetic joint infections remains paramount.
CHALLENGES OF PERIPROSTHETIC JOINT INFECTION
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) analyses are currently utilized in many orthopedic practices as standard serology tests aimed at assessing joint infection. In 2009, threshold levels, with optimal sensitivity and specificity, were determined that significantly aided the clinical diagnosis of infection in hip revision cases. Based on available literature, this was the first study of its kind to statistically determine an ideal cut-off value for ESR and CRP. Patients in this study were diagnosed with PJI if they met our institutional criteria for the diagnosis of infection. Using our infection database at the Rothman Institute, serology data was retrospectively collected and examined for ESR and CRP in 479 patients (26.5% infected 
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among six published sets of diagnostic criterion, which was then compared to a newly proposed set of criteria (8) (9) (10) (11) (12) 26) . Overall, there were 41 cases (24%) where infection diagnosis conflicted between studies (27) . According to the proposed new diagnostic criteria, PJI was suspected when one of the four parameters listed in Table II showed a positive result.
The results of our study showed an infected/uninfected ratio of 92/80. There was a large variance in sensitivity (54-100%), specificity (39-100%), and accuracy (53-100%) when referenced against each of the previously established criterion (27) . Interestingly, five cases were identified as infected by our proposed criteria while at least 4 of the existing sets had labeled it as uninfected. These five cases were culture negative and had no observed purulence or sinus tract intraoperatively. They were only diagnosed as infected because of elevated molecular markers from serum or synovial fluid.
The discrepancy between definitions of infection serves to highlight the importance of preoperative identification of PJI using our new criteria. In order to properly plan and treat revision patients, specific and firm universal criteria must be put in place. we believe that a common set of diagnostic criteria that accounts for aspirate analysis will improve the treatment of PJI. Shortcomings of available tests for the diagnosis of PJI motivated members of the orthopedic community to focus research efforts on the development of more accurate diagnostic criteria. Most tests are either expensive (radiology scans), subjective in their interpretation (frozen sections), not specific enough (ESR/CRP/wBC counts in serum), or simply time-consuming (culture). In December of 2010, a collaboration between several orthopedic
ESTABLISHMENT OF A DIAGNOSTIC CRITERION
After statistically defining ESR and CRP cut-off values, research efforts were focused on utilizing molecular diagnostics to create a diagnostic criterion for PJI. In a retrospective study, data was collected on 172 revision TKA cases at our institution between April 2002 and November 2009. These cases were used to evaluate the variation 
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5 uninfected) (Genway Biotech, San Diego, CA, USA). All preoperative serum CRP samples (68 samples; 29 infected, 39 uninfected) were analyzed by review of data from hospital records. For each assay, sensitivity, specificity, and ROC curve analyses was generated using our institutional diagnostic criteria (34) (Tab. V). The findings of this study indicate that CRP concentrations in the synovial fluid rather than in blood serum improves the diagnostic accuracy of this test in identifying PJI, making CRP a promising biomarker in this field.
The results spurred further study of CRP using larger sample sizes as well as the expansion of the current cohort to include patients with failed hip arthroplasties. In our prospective study, synovial fluid samples collected from patients undergoing primary and revision TJA are investigated for any correlation between synovial and serum CRP levels as well as white blood cell count and differential. Interim analysis of 97 synovial fluid samples from 97 patients, 33 diagnosed with PJI and 64 not infected, shows statistically significant differences between the groups for serum CRP, synovial fluid CRP, ESR, synovial wBC count, and neutrophil differential (p<0.001). The mean aseptic synovial fluid CRP value was 1.64 mg/l while the mean septic synovial fluid CRP value was 46.27 mg/l (p<0.0001). An ROC curve shows 84.8% sensitivity, 95.5% specificity, at a CRP synovial fluid threshold of 9.5 mg/l and an AUC of 0.93. Although this data is not finalized, we are hopeful that CRP will continue to show promise for the development of a quick, easy, and low-cost molecular diagnostic tool. 
C-REACTIVE PROTEIN (CRP)
Ongoing efforts aimed at finding a gold standard diagnostic test have brought great attention to CRP in synovial fluid. This promising biomarker has potential to serve as a low-cost diagnostic tool for PJI. CRP is a common serology test that is easily analyzed under routine hospital laboratory conditions. RBM analysis of CRP showed a threshold level of 3.605 mg/l in synovial fluid analysis with a sensitivity of 87.1%, specificity of 97.7%, PPV of 96.4%, NPV of 91.5% and an accuracy of 93.3% (28) . Based on this data, our goal was to investigate whether the accuracy of standard CRP assay for detection of PJI could be improved by measuring CRP in synovial fluid. Synovial fluid specimens were collected in the operating room before arthroplasty from 72 cases of revision total knee arthroplasty in order to calculate the concentration of synovial CRP to determine the sensitivity, specificity, PPV, and NPV (34) . These samples were all labeled and classified as infected or uninfected based on our institutional criteria for diagnosis of PJI. All 72 (29 infected, 43 uninfected) samples that were sent to RBM to be run on a multiplex immunoassay platform and 15 samples were also analyzed using CRP ELISA kit (10 infected and 
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as expected (35) . The ease, speed, and relative low-cost of the LE strip test make it very desirable as an adjunct molecular diagnostic tool for orthopedic surgeons. while the final role of this leukocyte esterase test is to be determined, the high PPV of a ++ result (strongly positive) and the high NPV of a negative/trace result (negative) indicate its value as a diagnostic tool which can serve to increase preoperative planning because of a clear diagnosis. Future directions for this study aim to expand the cohort, decrease reader bias using electronic readers, and investigate ways to include samples that are contaminated with blood which can currently skew results of this colorimetric test. Improvement in these areas would hopefully enable the use of leukocyte esterase to be utilized in the diagnosis of PJI.
MISSING THE MARK: CULTURE-NEGATIVE INFECTIONS
It is important to mention a specific subset of patients diagnosed with PJI at our institution who lack a positive culture result. without a causative organism, a significant road block is created not only in the surgical planning but also in the choice of anti-infective agent used by the surgeon. Even though there is a significant success rate associated with current treatments like irrigation and debridement (I&D), two-stage or one-stage revision, these cases must be considered in order to determine the best treatment plan. Expansion of this data set is part of current research efforts at our institution. Presently, the LE strip test boasts high sensitivity and specificity for diagnosis of PJI. Our results approach and even exceed those of several standard tests that are currently implemented (7, 9) . Additionally, this data is was investigated for any correlation with typical serology findings associated with PJI such as ESR, CRP, fluid wBC, and polymorphonuclear leukocyte counts (PMN). Strongest correlation was found with PMN % (r=0.7769), to culture-positive cases treated during the same time frame. Surgical intervention for these 48 cases included: I&D (13), one-stage exchange arthroplasty (3), and planned two-stage exchange arthroplasty (6) (Tab. VII).
There is reason to believe that the most likely cause for these suboptimal results for culture-negative PJI cases stems from an inability to isolate a pathogen from conventional culture. This ongoing study serves to underscore the importance of additional efforts to identify fungi or atypical pathogens that could be the cause of CN PJI. One such effort focused on the use of a new molecular diagnostic tool called IBIS T5000 Biosensor in an attempt to uncover a causative organism in CN cases of PJI. This technology utilizes pan-genomic primers in a series of polymerase chain reactions to identify known pathogens and virulence genes. Using mass spectrometry to asses the base composition of an identified region of DNA, this technology identifies specific genes, such as the mecA gene for methicillin resistance, giving surgeons important information about the type of pathogen isolated from the joint. These results, combined with the PCR results, are then compared to 
